Psychiatry Investig.  2024 Feb;21(2):165-173. 10.30773/pi.2023.0352.

Reliability and Validity of the Korean Version of the Somatic Symptom Disorder-B Criteria Scale in a Clinical Population

Affiliations
  • 1Department of Psychiatry, Korea University Ansan Hospital, Ansan, Republic of Korea
  • 2Department of Neuropsychiatry, Seoul National University Hospital, Seoul, Republic of Korea
  • 3Department of Psychiatry and Behavioral Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea
  • 4Seoul Regional Military Manpower Administration, Seoul, Republic of Korea
  • 5Department of Psychiatry, Armed Forces Hampyeong Hospital, Hampyeong, Republic of Korea
  • 6Department of Psychiatry, Korea Army Training Center District Hospital, Nonsan, Republic of Korea
  • 7Department of Psychiatry, Dongguk University Ilsan Hospital, Goyang, Republic of Korea
  • 8Institute of Human Behavioral Medicine, Medical Research Center, Seoul National University, Seoul, Republic of Korea
  • 9Department of Psychiatry, Uijeongbu Eulji Medical Center, Eulji University School of Medicine, Uijeongbu, Republic of Korea

Abstract


Objective
This study aimed to develop and validate the Korean version of the Somatic Symptom Disorder-B Criteria Scale (SSD-12) in outpatients at a psychiatric clinic and assess its diagnostic accuracy.
Methods
A total of 207 patients completed SSD-12. For the diagnostic accuracy of SSD-12, the somatic symptom disorder (SSD) section of the structured clinical interview for DSM-5 disorders-research version (SCID-5-RV) was used. The SSD-12 construct and concurrent validity were assessed by examining the correlations with Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-9 (PHQ-9), PHQ-15, 5-level EQ-5D version (EQ-5D-5L), and World Health Organization Quality of Life Brief Version (WHOQOL-BREF).
Results
The SSD-12 had excellent internal consistency (Cronbach α=0.90). Confirmatory factor analysis revealed good fit indices for a general factor model (comparative fit index [CFI]=0.92, Tucker-Lewis index [TLI]=0.88, root mean square error of approximation [RMSEA]=0.10; 95% confidence interval [CI], 0.08–0.11) and a three-factor model (CFI=0.94, TLI=0.91, RMSEA=0.08; 95% CI, 0.07–0.10). The total SSD-12 score was significantly correlated with anxiety (GAD-7: r=0.53, p<0.001), depression (PHQ-9: r=0.52, p<0.001), physical symptom burden (PHQ-15: r=0.36, p<0.001), and quality of life (EQ-5D-5L: r=-0.40, p<0.001; WHOQOL-BREF: r=-0.51, p<0.001). SSD-12 demonstrated good accuracy (area under the curve=0.75, standard error=0.04; 95% CI, 0.68–0.82) with an optimal cut-off of 29.
Conclusion
The Korean SSD-12 demonstrates reliability and validity for diagnosing SSD in clinical setting.

Keyword

Somatic Symptom Disorder?B Criteria Scale; SSD-12; Reliability; Validity; Cut-off
Full Text Links
  • PI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr